| Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) / J&J, Gilead |
2018-001645-14: Study to compare two treatments in patients who have never taken HIV medication randomized in different centers in Spain. (The Symtri study) Estudio para comparar dos tratamientos en pacientes que nunca han tomado medicación para el VIH asignados al azar realizado en diferentes centros de España. (Estudio SYMTRI) |
|
|
| Ongoing | 4 | 316 | Europe | Film-coated tablet, Symtuza, Triumeq | Spanish HIV/AIDS Research Networkº, Spanish HIV/AIDS Research Network | HIV infection Infección por VIH, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02] | | | | |
| Ongoing | 4 | 110 | Europe | Symtuza, Tablet, Symtuza, Triumeq | Fundación SEIMC-GESIDA, JANSSEN CILAG S.A | HIV VIH, HIV VIH, Diseases [C] - Virus Diseases [C02] | | | | |
2019-004620-38: Study to see the changes in body weight and body composition of a darunavir/cobicistat based treatment in HIV-infected people who have gained weight during a dolutegravir-based treatment. Estudio para ver los cambios en el peso y la composición del cuerpo de un tratamiento basado en darunavir/cobicistat en personas con infección por el VIH que han aumentado de peso durante un tratamiento basado en dolutegravir. |
|
|
| Not yet recruiting | 4 | 60 | Europe | Triumeq, Rezolsta, Kivexa, Symtuza, Film-coated tablet, Triumeq, Rezolsta, Kivexa, Symtuza | Fundació Lluita contra la SIDA, Fundació Lluita contra la SIDA | HIV infection Infección por el VIH, HIV infection Infección por el VIH, Diseases [C] - Immune System Diseases [C20] | | | | |
NCT04442737: A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain |
|
|
| Completed | 4 | 103 | US | D/C/F/TAF FDC, TAF/FTC FDC, INI Based Regimen | Janssen Scientific Affairs, LLC | HIV-1 | 08/23 | 08/23 | | |
ReSTART, NCT04388904: Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. |
|
|
| Completed | 4 | 75 | US | Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (FDC) | The Crofoot Research Center, Inc., Janssen Scientific Affairs, LLC | HIV-1-infection | 04/24 | 04/24 | | |
NCT05463783: Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain |
|
|
| Recruiting | 4 | 30 | US | Biktarvy, bictegravir/emtricitabine/tenofovir alafenamide, Symtuza, darunavir/cobicistat/emtricitabine/tenofovir alafenamide | East Carolina University, Janssen Scientific Affairs, LLC | HIV Infections, Obesity | 03/25 | 03/25 | | |
2018-003481-13: An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV Disease -The Late Presenter Treatment Optimisation Study (LAPTOP)- |
|
|
| Not yet recruiting | 3 | 440 | Europe | Biktarvy, Symtuza, [J05AR], [J05AR22], Film-coated tablet, Biktarvy, Symtuza | NEAT ID Foundation, Gilead Sciences Inc, Janssen Pharmaceutica NV, Gilead Sciences, Inc., | Patients who present late on during their acquisition of the HIV-1 (Human Immunodeficiency Virus), A virus that damages patient's immune system causing the patient difficulty to fight off infections and diseases., Diseases [C] - Virus Diseases [C02] | | | | |
2022-001437-36: ITACO study and the Analytical Antiretroviral Treatment Interruption study (ITACO-ATI) Studio ITACO e studio sull'interruzione del Trattamento Antiretrovirale (ITACO-ATI) |
|
|
| Not yet recruiting | 3 | 61 | Europe | ODEFSEY, REZOLSTA, BIKTARVY, Triumeq, Edurant, Tivicay, Descovy, Symtuza, Dovato, Epivir, [na], Film-coated tablet, ODEFSEY - 200 MG/25 MG/25 MG- COMPRESSA RIVESTITA- USO ORALE- FLACONE (HDPE) 30 COMPRESSE, REZOLSTA - 800 MG/ 150 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE-FLACONE (HDPE)- 30 COMPRESSE, Biktarvy, TRIUMEQ - 50MG/600MG/300 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE HDPE - 1 FLACONE 30 COMPRESSE, EDURANT - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) 30 COMPRESSE, TIVICAY - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, DESCOVY - 200 MG/10 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- FLACONE (HDPE)- 30 COMPRESSE, Symtuza, DOVATO - 50 MG / 300 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, EPIVIR - 300 MG 1 FLACONE 30 COMPRESSE RIVESTITE CON FILM USO ORALE | IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA, NIH (Johns Hopkins University) | perinatally HIV infection Infezione da HIV perinatale, perinatally HIV infection Infezione da HIV perinatale, Diseases [C] - Immune System Diseases [C20] | | | | |
| Completed | 3 | 36 | Europe | Biktarvy, Symtuza | Chelsea and Westminster NHS Foundation Trust, Imperial College London, Gilead Sciences | Human Immunodeficiency Virus | 07/23 | 07/23 | | |
NCT03696160: The Late Presenter Treatment Optimisation Study |
|
|
| Active, not recruiting | 3 | 447 | Europe | Biktarvy, Symtuza | NEAT ID Foundation, Gilead Sciences, Janssen Pharmaceuticals | HIV/AIDS | 06/24 | 06/24 | | |